| |
|
HBV | Abstract Library |
 |
| |
| The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors. |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 8. | Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care |
| |
Liver Int. 2022 Sep 1. doi: 10.1111/liv.15414. Online ahead of print.
Rachael Jacob 1 2, David S Prince 1 2, Joseph L Pipicella 1 3, Angela Nguyen 1 4, Melissa Bagatella 1, Frank Alvaro 1 5, Michael Maley 1 3 5, Hong Foo 1 5, Paul Middleton 1 2 6, Tahrima Kayes 1, Julia DiGirolamo 1, Scott A Davison 1 2, Miriam T Levy 1 2 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 15. | The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study |
| |
HIV Med. 2022 Jul;23(6):585-598. doi: 10.1111/hiv.13210. Epub 2021 Dec 9.
Amanda Mocroft 1 2, Jose M Miro 3, Gilles Wandeler 4, Josep M Llibre 5, Anders Boyd 6 7, Kathrin van Bremen 8, Marek Beniowski 9, Julia Mikhalik 10, Matthias Cavassini 11, Fernando Maltez 12, Claudine Duvivier 13 14 15 16, Caterina Uberti Foppa 17, Brygida Knysz 18, Elzbieta Bakowska 19, Elena Kuzovatova 20, Pere Domingo 21, Alexandra Zagalo 22, Jean-Paul Viard 23, Olaf Degen 24, Ana Milinkovic 25, Thomas Benfield 26, Lars Peters 1, EuroSIDA study group
|
|
| |
|
|
| |
| 17. | Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection |
| |
Clin Gastroenterol Hepatol. 2022 Jul 16;S1542-3565(22)00653-X.doi: 10.1016/j.cgh.2022.06.015. Online ahead of print.
Jordan J Feld 1, Wendy C King 2, Marc G Ghany 3, Kyong-Mi Chang 4, Norah Terrault 5, Robert P Perrillo 6, Mandana Khalili 7, Amanda S Hinerman 2, Harry LA Janssen 8, Anna S Lok 9, Hepatitis B Research Network (HBRN)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 22. | Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance |
| |
Clin Gastroenterol Hepatol. 2022 Jul 16;S1542-3565(22)00660-7.doi: 10.1016/j.cgh.2022.06.019. Online ahead of print.
Wendy C King 1, Richard K Sterling 2, Amanda S Hinerman 3, Anna S F Lok 4, Gavin A Cloherty 5, Marc G Ghany 6, HBRN HBV Novel Assays Group (Corporate authorship); Abdus S Wahed 7, Raymond T Chung 8, Harry L A Janssen 9, Mandana Khalili 10, Daryl T Y Lau 11, William M Lee 12, Mauricio Lisker-Melman 13, Norah Terrault 14
|
|
| |
|
|
| |
| 24. | Predicting hepatitis B e Antigen seroconversion after pregnancy-The SydPregScore |
| |
Liver Int. 2022 Jul 21. doi: 10.1111/liv.15372. Online ahead of print.
Cynthuja Thilakanathan 1 2, Tahrima Kayes 1, Julia Di Girolamo 1, Vi Nguyen 2, Anne Glass 1, Sicha Manandhar 1, Joseph Lawler 3, Chris Meredith 3, Michael Maley 2 4, Andrew Lloyd 5, Miriam T Levy 1 2
|
|
| |
|
|
| |
|
|
| |
| 27. | Hepatitis B Virus Reactivation Associated with New Classes of Immunosuppressants and Immunomodulators: A Systematic Review, Meta-analysis, and Expert Opinion |
| |
J Hepatol. 2022 Jul 15;S0168-8278(22)02935-X. doi: 10.1016/j.jhep.2022.07.003.Online ahead of print.
George V Papatheodoridis 1, Vasileios Lekakis 1, Thodoris Voulgaris 2, Pietro Lampertico 3, Thomas Berg 4, Henry L Y Chan 5, Jia-Horng Kao 6, Norah Terrault 7, Anna S Lok 8, K Rajender Reddy 9
|
|
| |
| 28. | Improving Hepatitis B Vaccination Rates among At-risk Children and Adolescents with Inflammatory Bowel Disease |
| |
Pediatr Qual Saf. 2022 Jun 23;7(4):e570. doi: 10.1097/pq9.0000000000000570.eCollection 2022 Jul-Aug.
Megan Megan McNicol 1, Amy Donegan 2, Kate Hawa 3, Angelique E Boutzoukas 3, Barb Drobnic 2, Melanie Oates 2, Maudie Orraca-Tetteh 2, Hilary K Michel 2, Ross M Maltz 2, Jennifer L Dotson 2, Don Buckingham 4, Brendan Boyle 2, Monica I Ardura 5
|
|
| |
| 29. | Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection |
| |
J Hepatol. 2022 Jun 10;S0168-8278(22)00348-8. doi: 10.1016/j.jhep.2022.05.027.Online ahead of print.
Mark S Sulkowski 1, Kosh Agarwal 2, Xiaoli Ma 3, Tuan T Nguyen 4, Eugene R Schiff 5, Hie-Won L Hann 6, Douglas T Dieterich 7, Ronald G Nahass 8, James S Park 9, Sing Chan 10, Steven-Huy B Han 11, Edward J Gane 12, Michael Bennett 13, Katia Alves 14, Marc Evanchik 14, Ran Yan 14, Qi Huang 14, Uri Lopatin 14, Richard Colonno 14, Julie Ma 14, Steven J Knox 14, Luisa M Stamm 14, Maurizio Bonacini 15, Ira M Jacobson 9, Walid S Ayoub 16, Frank Weilert 17, Natarajan Ravendhran 18, Alnoor Ramji 19, Paul Yien Kwo 20, Magdy Elkhashab 21, Tarek Hassanein 22, Ho S Bae 23, Jacob P Lalezari 15, Scott K Fung 24, Man-Fung Yuen 25
|
|
| |
|
|
| |
| 31. | Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection |
| |
Aliment Pharmacol Ther. 2022 Aug;56(3):510-518. doi: 10.1111/apt.17040. Epub 2022 May 22.
Tahrima Kayes 1 2, Harry Crane 1 2, Allison Symonds 3, Julie Dumond 3, Mackenzie Cottrell 3, Julia Di Girolamo 1 2, Sicha Manandhar 1 2, Tien Huey Lim 4, Edward Gane 5, Angela Kashuba 3, Miriam T Levy 1 2 6
|
|
| |
| 32. | Updated U.S. Public Health Service Guideline for Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus - United States, 2022 |
| |
MMWR Morb Mortal Wkly Rep. 2022 Jul 1;71(26):844-846. doi: 10.15585/mmwr.mm7126a2.
Rebecca J Free, Marilyn E Levi, James S Bowman, Danae Bixler, John T Brooks, Kate Buchacz, Anne Moorman, James Berger, Sridhar V Basavaraju
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 46. | Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis |
| |
JAMA Netw Open. 2022 Jun 1;5(6):e2219407.doi: 10.1001/jamanetworkopen.2022.19407.
Darren Jun Hao Tan 1, Cheng Han Ng 1, Phoebe Wen Lin Tay 1, Nicholas Syn 1, Mark D Muthiah 1 2 3, Wen Hui Lim 1, Ansel Shao Pin Tang 1, Kai En Lim 1, Grace En Hui Lim 4, Nobuharu Tamaki 5, Beom Kyung Kim 5 6 7, Margaret Li Peng Teng 1 2 3, James Fung 8, Rohit Loomba 9, Mindie H Nguyen 10, Daniel Q Huang 1 2 3 9
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 50. | Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels |
| |
Aliment Pharmacol Ther. 2022 May 6. doi: 10.1111/apt.16968. Online ahead of print.
Samuel A L Hall 1 2, Gareth S Burns 1 2, Despina Anagnostou 1, Sara Vogrin 2, Vijaya Sundararajan 2 3, Dilip Ratnam 4 5, Miriam T Levy 6, John S Lubel 7 8, Amanda J Nicoll 9, Simone I Strasser 10 11, William Sievert 4 5, Paul V Desmond 1, Meng C Ngu 12, Peter Angus 13 14, Marie Sinclair 13, Christopher Meredith 15, Gail Matthews 16, Peter A Revill 17, Kathy Jackson 17, Margaret Littlejohn 17, D Scott Bowden 17, Stephen A Locarnini 17, Kumar Visvanathan 1 2, Alexander J Thompson 1 2
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 54. | Australian consensus recommendations for the management of hepatitis B |
| |
Med J Aust. 2022 May 16;216(9):478-486. doi: 10.5694/mja2.51430. Epub 2022 Mar 6.
John S Lubel 1 2, Simone I Strasser 3 4, Alexander J Thompson 5 6, Benjamin C Cowie 7 8, Jennifer MacLachlan 7, Nicole L Allard 6 7, Jacinta Holmes 5 6, William W Kemp 1, Avik Majumdar 3, David Iser 5, Jess Howell 2 6 9, Gail V Matthews 10 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 66. | Review article: switching patients with chronic hepatitis B to tenofovir alafenamide-a review of current data |
| |
Aliment Pharmacol Ther. 2022 Apr;55(8):921-943. doi: 10.1111/apt.16788.Epub 2022 Feb 17.
Young-Suk Lim 1, Wai-Kay Seto 2 3, Masayuki Kurosaki 4, Scott Fung 5, Jia-Horng Kao 6, Jinlin Hou 7, Stuart C Gordon 8, John F Flaherty 9, Leland J Yee 9, Yang Zhao 9, Kosh Agarwal 10, Pietro Lampertico 11 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 75. | Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy |
| |
Hepatol Int. 2022 Apr;16(2):211-253. doi: 10.1007/s12072-021-10285-5.Epub 2022 Feb 3.
Manoj Kumar 1, Zaigham Abbas 2, Milad Azami 3, Maria Belopolskaya 4, A K Dokmeci 5, Hasmik Ghazinyan 6, Jidong Jia 7, Ankur Jindal 8, Han Chu Lee 9, Wei Lei 10, Seng Gee Lim 11, Chun-Jen Liu 12, Qiang Li 13, Mamun Al Mahtab 14, David H Muljono 15, Madunil Anuk Niriella 16, Masao Omata 17 18, Diana A Payawal 19, Shiv K Sarin 20, Olivier Ségéral 21, Tawesak Tanwandee 22, Nirupma Trehanpati 23, Kumar Visvanathan 24, Jin Mo Yang 25, Man-Fung Yuen 26, Yingjie Zheng 27, Y H Zhou 28
|
|
| |
|
|
| |
|
|
| |
| 78. | The viral hepatitis B care cascade: A population-based comparison of immigrant groups |
| |
Hepatology. 2022 Mar;75(3):673-689. doi: 10.1002/hep.32162. Epub 2021 Dec 7.
Abdool S Yasseen 1 2 3, Jeffrey C Kwong 1 2 3 4 5, Jordan J Feld 1 2 4 6, Rafal Kustra 1, Liane MacDonald 1 3, Christina C Greenaway 7 8 9, Naveed Z Janjua 10, Tony Mazzulli 3 4, Morris Sherman 4, Lauren Lapointe-Shaw 2 4 6, Beate Sander 1 2 3 4, Natasha S Crowcroft 1 2 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 84. | Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection |
| |
J Antimicrob Chemother. 2022 Mar 31;77(4):1102-1110.doi: 10.1093/jac/dkab491.
Ed J Gane 1, Christian Schwabe 2, Elina Berliba 3 4, Pisit Tangkijvanich 5, Alina Jucov 3 4, Nelea Ghicavii 3, Thierry Verbinnen 6, Oliver Lenz 6, Willem Talloen 6, Thomas N Kakuda 7, Chris Westland 7, Megha Patel 7, Jeysen Z Yogaratnam 7, Leonard Dragone 7, Pieter Van Remoortere 8
|
|
| |
|
|
| |
|
|
| |
| 87. | Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study |
| |
J Viral Hepat. 2021 Dec;28(12):1690-1698. doi: 10.1111/jvh.13608.Epub 2021 Sep 29.
Robin Erken 1, Patrice Andre 2, Elise Roy 3, Neeltje Kootstra 4, Noelie Barzic 3, Hugo Girma 3, Christian Laveille 5, Pauline Radreau-Pierini 3, Raphael Darteil 3, Jacky Vonderscher 3, Pietro Scalfaro 3, Pisit Tangkijvanich 6, Robert Flisiak 7, Henk Reesink 8
|
|
| |
|
|
| |
| 89. | Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner |
| |
Vaccine. 2022 Feb 23;40(9):1334-1341.doi: 10.1016/j.vaccine.2022.01.005. Epub 2022 Jan 31.
Laure F Pittet 1, Lianne Cox 2, Bridget Freyne 3, Susie Germano 4, Rhian Bonnici 5, Kaya Gardiner 6, Susan Donath 7, Clare L Collins 8, Dan Casalaz 9, Roy Robins-Browne 10, Katie L Flanagan 11, Nicole L Messina 12, Nigel Curtis 13
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 93. | Incidence of malignancies among patients with chronic hepatitis B in US health care organizations, 2006-2018 |
| |
J Infect Dis. 2022 Jan 17;jiac011. doi: 10.1093/infdis/jiac011. Online ahead of print.
Philip R Spradling 1, Jian Xing 1, Y Zhong 1, Loralee B Rupp 2, Anne C Moorman 1, Mei Lu 2, Eyasu H Teshale 1, Mark A Schmidt 3, Yihe G Daida 4, Joseph A Boscarino 5, Stuart C Gordon 2 6, Chronic Hepatitis Cohort Study (CHeCS) Investigators
|
|
| |
| 94. | Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection |
| |
J Hepatol. 2022 Mar 5;S0168-8278(22)00127-1. doi: 10.1016/j.jhep.2022.02.020.Online ahead of print.
Adam J Gehring 1, Patricia Mendez 2, Kirsten Richter 3, Hildegund Ertl 4, Eric F Donaldson 5, Poonam Mishra 5, Mala Maini 6, Andre Boonstra 7, Georg Lauer 8, An de Creus 9, Kathleen Whitaker 10, Sara Ferrando Martinez 11, Jessica Weber 12, Emily Gainor 12, Veronica Miller 12
|
|
| |
| 95. | Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose |
| |
Hepatology. 2022 Mar 23. doi: 10.1002/hep.32474. Online ahead of print.
Michael G Bruce 1, Dana Bruden 1, Debby Hurlburt 1, Julie Morris 1, Sara Bressler 1, Gail Thompson 1, Danielle Lecy 1, Karen Rudolph 1, Lisa Bulkow 1, Thomas Hennessy 1, Brenna C Simons 1, Mark K Weng 2, Noele Nelson 2, Brian J McMahon 1 3
|
|
| |
|
|
| |
| 97. | Immunological Biomarker Discovery in Cure Regimens for Chronic Hepatitis B Virus Infection |
| |
J Hepatol. 2022 Mar 5;S0168-8278(22)00127-1. doi: 10.1016/j.jhep.2022.02.020.Online ahead of print.
Adam J Gehring 1, Patricia Mendez 2, Kirsten Richter 3, Hildegund Ertl 4, Eric F Donaldson 5, Poonam Mishra 5, Mala Maini 6, Andre Boonstra 7, Georg Lauer 8, An de Creus 9, Kathleen Whitaker 10, Sara Ferrando Martinez 11, Jessica Weber 12, Emily Gainor 12, Veronica Miller 12
|
|
| |
| 98. | Protection and Antibody Levels 35 Years after Primary Series with Hepatitis B Vaccine and Response to a Booster Dose |
| |
Hepatology. 2022 Mar 23. doi: 10.1002/hep.32474. Online ahead of print.
Michael G Bruce 1, Dana Bruden 1, Debby Hurlburt 1, Julie Morris 1, Sara Bressler 1, Gail Thompson 1, Danielle Lecy 1, Karen Rudolph 1, Lisa Bulkow 1, Thomas Hennessy 1, Brenna C Simons 1, Mark K Weng 2, Noele Nelson 2, Brian J McMahon 1 3
|
|
| |
|
|
| |
| 100. | Serological testing on the ADVIA Centaur system for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in specimens from deceased and living individuals demonstrates equivalent results l |
| |
Transpl Infect Dis. 2022 Feb 17;e13802. doi: 10.1111/tid.13802. Online ahead of print.
Theodore B Wright 1, Sai Patibandla 1, Renee Walsh 1, Rachel Fonstad 1, Matthew Gee 1, Vera Bitcon 1, Julie Hopper 2, Susie J Braniff 3, Susan Best 3, Scott Read 4
|
|
| |
| 101. | Assessing the cost-utility of universal hepatitis B vaccination among adults |
| |
J Infect Dis. 2022 Mar 9;jiac088. doi: 10.1093/infdis/jiac088. Online ahead of print.
Eric W Hall 1 2, Mark K Weng 3, Aaron M Harris 3, Sarah Schillie 4, Noele P Nelson 3, Ismael R Ortega-Sanchez 4, Elizabeth Rosenthal 5, Patrick S Sullivan 2, Ben Lopman 2, Jeb Jones 2, Heather Bradley 6, Eli S Rosenberg 5 7
|
|
| |
| 102. | Aspirin Use and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B With or Without Cirrhosis |
| |
Hepatology. 2022 Jan 31. doi: 10.1002/hep.32380. Online ahead of print.
Heejoon Jang 1 2, Yun Bin Lee 1, Hyemi Moon 3, Jong-Won Chung 4, Joon Yeul Nam 1, Eun Ju Cho 1, Jeong-Hoon Lee 1, Su Jong Yu 1, Yoon Jun Kim 1, Juneyoung Lee 3, Jung-Hwan Yoon 1
|
|
| |
| 103. | Hepatitis B surface antigen and Hepatitis B RNA changes in HIV/HBV Co-infected participants receiving HBV-active antiretroviral therapy for 144 weeks |
| |
AIDS. 2022 Feb 14. doi: 10.1097/QAD.0000000000003193. Online ahead of print.
Claudia Hawkins 1, Minhee Kang, Debika Bhattacharya, Gavin Cloherty, Mary Kuhns, Roy Matining, Chloe Thio, Wadzanai Samaneka, Lameck Chinula, Nyirenda Mulinda, Sharlaa Badal-Faesen, Patcharaphan Sugandhavesa, Javier Lama, Simani Gaseitsiwe, Vera Holzmayer, Mark Anderson, Robert Murphy, Marion Peters
|
|
| |
|
|
| |
| 105. | Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults |
| |
Dig Dis Sci. 2022 Feb;67(2):676-688. doi: 10.1007/s10620-021-06860-3. Epub 2021 Feb 8.
Richard K Sterling 1, Wendy C King 2, Mandana Khalili 3, David E Kleiner 4, Amanda S Hinerman 2, Mark Sulkowski 5, Raymond T Chung 6, Mamta K Jain 7, M Auricio Lisker-Melman 8, David K Wong 9, Marc G Ghany 4, HBV-HIV Cohort Study of the Hepatitis B Research Network
|
|
| |
| 106. | Chronic Hepatitis Is Common and Often Untreated Among Children with Hepatitis B Infection in the United States and Canada |
| |
J Pediatr. 2021 Oct;237:24-33.e12. doi: 10.1016/j.jpeds.2021.05.035.Epub 2021 May 20.
Simon C Ling 1, Hsing-Hua S Lin 2, Karen F Murray 3, Philip Rosenthal 4, Douglas Mogul 5, Norberto Rodriguez-Baez 6, Sarah Jane Schwarzenberg 7, Jeffrey Teckman 8, Kathleen B Schwarz 5, Hepatitis B Research Network (HBRN)
Hepatitis B Research Network (HBRN):
Hongxia Li, Robert Anders, Hejab Imteyaz, Peter Lee, Kiyoko Oshima, Kim Kafka, Naureen Islam, Shannon M Riggs, Rosemary A Nagy, Jacki Cerkoski, Athena Hau, Daniel Cui, Laurie A Rodgers-Augustyniak, Shirley Montanye, Natasha Feier, Joel Feier, Camille Langlois, Kara L Cooper, Jay H Hoofnagle, Averell H Sherker, Edward Doo, Rebecca J Torrance, Sherry R Hall, Frani Averbach, Tamara Haller, Regina Hardison, Stephanie Kelley, Christina M Lalama, Sharon Lawlor, Manuel Lombardero, Andrew Pelesko, Donna Stoliker, Melissa Weiner, Ella Zadorozny, Qian Zhao
|
|
| |
| 107. | Changes in serum hepatitis B surface and e antigen, IP-10, and aminotransferase levels during combination therapy of immune tolerant chronic hepatitis B |
| |
Hepatology. 2022 Feb 21. doi: 10.1002/hep.32400. Online ahead of print.
Robert P Perrillo 1, Hsing-Hua S Lin 2, Kathleen B Schwarz 3, Philip Rosenthal 4, Mauricio Lisker-Melman 5, Raymond T Chung 6, Ludmila Prokunina-Olsson 7, Gavin Coherty 8, Jordan Feld 9, Hepatitis B Research Network (HBRN)
|
|
| |
|
|
| |
| 109. | Outbreak of hepatitis B and hepatitis C virus infections associated with a cardiology clinic, West Virginia, 2012-2014 |
| |
Infect Control Hosp Epidemiol. 2021 Dec;42(12):1458-1463. doi: 10.1017/ice.2021.31.Epub 2021 Mar 1.
Stacy R Tressler 1, Maria C Del Rosario 1, Michelle D Kirby 2, Ashley N Simmons 1, Melissa A Scott 1, Sherif Ibrahim 1, Joseph C Forbi 3, Hong Thai 3, Guo-Liang Xia 3, Meghan Lyman 4, Melissa G Collier 3, Priti R Patel 4, Danae Bixler 1
|
|
| |
|
|
| |
| 111. | Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels |
| |
J Hepatol. 2022 Jan 26;S0168-8278(22)00020-4. doi: 10.1016/j.jhep.2022.01.007.Online ahead of print.
M J Sonneveld 1, S-M Chiu 2, J Y Park 3, S M Brakenhoff 4, A Kaewdech 5, W K Seto 6, Y Tanaka 7, I Carey 8, M Papatheodoridi 9, F van Bömmel 10, T Berg 11, F Zoulim 12, S H Ahn 13, G N Dalekos 14, N S Erler 15, C Höner Zu Siederdissen 16, H Wedemeyer 17, M Cornberg 18, M F Yuen 19, K Agarwal 20, A Boonstra 21, M Buti 22, T Piratvisuth 23, G Papatheodoridis 24, C-H Chen 25, B Maasoumy 26, CREATE study group
|
|
| |
|
|
| |
|
|
| |
| 114. | An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States |
| |
Hepatology. 2021 Aug;74(2):607-626. doi: 10.1002/hep.31782.Epub 2021 May 26.
Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
|
|
| |
|
|
| |
|
|
| |
| 117. | Hepatitis B vaccine coverage and risk factors for lack of vaccination in subjects with HBsAg negative liver cirrhosis in Italy: still, much work should be done |
| |
Dig Liver Dis. 2021 Oct;53(10):1315-1319. doi: 10.1016/j.dld.2020.10.011. Epub 2020 Nov 6.
Tommaso Stroffolini 1, Anna Lombardi 2, Alessia Ciancio 3, Rosanna Fontana 4, Guido Colloredo 5, Massimo Marignani 6, Maria Vinci 7, Filomena Morisco 8, Sergio Babudieri 9, Luigina Ferrigno 10, Evangelista Sagnelli 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 124. | Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial |
| |
Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.
Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
|
|
| |
|
|
| |
|
|
| |
| 127. | Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial |
| |
Nat Med. 2021 Oct;27(10):1725-1734. doi: 10.1038/s41591-021-01513-4.Epub 2021 Oct 12.
Man-Fung Yuen 1, Jeong Heo 2, Jeong-Won Jang 3, Jung-Hwan Yoon 4, Young-Oh Kweon 5, Sung-Jae Park 6, Yvonne Tami 7, Shihyun You 8, Phillip Yates 9, Yu Tao 8, Jennifer Cremer 10, Fiona Campbell 9, Robert Elston 9, Dickens Theodore 10, Melanie Paff 8, C Frank Bennett 7, T Jesse Kwoh 7
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 135. | Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy |
| |
Hepatology. 2021 Jun;73(6):2124-2140. doi: 10.1002/hep.31554. Epub 2021 May 21.
Anna S Lok 1, Robert Perrillo 2, Christina M Lalama 3, Michael W Fried 4, Steven H Belle 5, Marc G Ghany 6, Mandana Khalili 7, Robert J Fontana 1, Richard K Sterling 8, Norah Terrault 9, Jordan J Feld 10, Adrian M Di Bisceglie 11, Daryl T Y Lau 12, Mohamed Hassan 13, Harry L A Janssen 14, Hepatitis B Research Network (HBRN)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 143. | Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals |
| |
Aliment Pharmacol Ther. 2021 Jul 19. doi: 10.1111/apt.16524. Online ahead of print.
Jill Koshiol 1, Ilona Argirion 1, Zhiwei Liu 1, Tram Kim Lam 2, Thomas R O'Brien 1, Kelly Yu 1, Katherine A McGlynn 1, Jessica L Petrick 1 3, Ligia Pinto 4, Chien-Jen Chen 5 6, Allan Hildesheim 1, Ruth M Pfeiffer 1, Mei-Hsuan Lee 7, Hwai-I Yang 5
|
|
| |
| 144. | The Inflammatory Cytokine Profile Associated with Liver Damage is Broader and Stronger in Chronic Hepatitis B Patients Compared to Acute Hepatitis B Patients |
| |
J Infect Dis. 2021 Jul 21;jiab373. doi: 10.1093/infdis/jiab373. Online ahead of print.
Alexandra Johnson Valiente 1 2, Kin Seng Liem 2 3, Kathleen B Schwarz 4 5, Philip Rosenthal 6, Karen F Murray 7, Douglas Mogul 5, Jeffery Teckman 8, Norberto Rodriguez-Baez 9, Sarah Jane Schwarzenberg 10, Jordan J Feld 2 11, David K Wong 2, Lia L Lewis-Ximenez 12, Georg Lauer 13, Bettina E Hansen 2 14, Simon C Ling 15 16, Harry L A Janssen 2 11, Adam J Gehring 1 2 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 153. | Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019 |
| |
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):961-966. doi: 10.15585/mmwr.mm7027a1.
Danae Bixler, Pallavi Annambhotla, Martha P Montgomery, Tonya Mixon-Hayden, Ben Kupronis, Marian G Michaels, Ricardo M La Hoz, Sridhar V Basavaraju, Saleem Kamili, Anne Moorman
|
|
| |
|
|
| |
| 155. | Family imaginaries in the disclosure of a blood-borne virus |
| |
Sociol Health Illn. 2021 Jun 23. doi: 10.1111/1467-9566.13316. Online ahead of print.
Anthony K J Smith 1, Asha Persson 1, Kerryn Drysdale 1 2, Joanne Bryant 1, Kylie Valentine 3, Jack Wallace 4, Myra Hamilton 5, Rebecca M Gray 1, Christy E Newman 1
|
|
| |
| 156. | Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study |
| |
BMC Infect Dis. 2021 Jun 26;21(1):610. doi: 10.1186/s12879-021-06226-0.
Tingyan Wang 1 2, David A Smith 2 3, Cori Campbell 1 2, Jolynne Mokaya 1, Oliver Freeman 2 4, Hizni Salih 2 4, Anna L McNaughton 1, Sarah Cripps 5, Kinga A Várnai 2 3, Theresa Noble 2 3, Kerrie Woods 2 3, Jane Collier 6, Katie Jeffery 7, Jim Davies 2 8, Eleanor Barnes # 9 10, Philippa C Matthews # 11 12 13
|
|
| |
|
|
| |
| 158. | Comparison of Novel Biomarkers with Conventional HBV Markers among Untreated Adults with Chronic Hepatitis B in North America |
| |
Hepatology. 2021 Jun 16. doi: 10.1002/hep.32018. Online ahead of print.
Marc G Ghany 1, Wendy C King 2, Mauricio Lisker-Melman 3, Anna Sf Lok 4, Norah Terrault 5, Harry L A Janssen 6, Mandana Khalili 7, Raymond T Chung 8, William M Lee 9, Daryl T Y Lau 10, Gavin A Cloherty 11, Richard K Sterling 12
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 164. | Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study |
| |
BMC Public Health. 2021 May 28;21(1):1004. doi: 10.1186/s12889-021-11093-0.
Catherine Freeland 1 2, Sean Farrell 3 4, Priyanka Kumar 3 5, Maureen Kamischke 6, Michaela Jackson 6, Sierra Bodor 6, Timothy M Block 6, Rosemary Frasso 3, Chari Cohen 6
|
|
| |
| 165. | An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States |
| |
Hepatology. 2021 Mar 3. doi: 10.1002/hep.31782. Online ahead of print.
Robert J Wong 1 2, Carol L Brosgart 3, Sue Welch 4, Tim Block 5 6, Mark Chen 4, Chari Cohen 5 6, W Ray Kim 1, Kris V Kowdley 7, Anna S Lok 8, Naoky Tsai 9, John Ward 10, Steven S Wong 4, Robert G Gish 5
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 170. | Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C |
| |
J Viral Hepat. 2021 May 18. doi: 10.1111/jvh.13545. Online ahead of print.
Erika Duffell 1, Helena Cortez-Pinto 2, Marieta Simonova 3, Olav Dalgard 4, Elin Hoffmann Dahl 5, Catherine de Martel 6, Antons Mozalevskis 7, Maria Buti 8, Slava Pavlova 3, Tnaiq Hadzhilova 3, Carolina Simões 2, Krum Katzarov 3, Otilia Mardh 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 178. | Robust hepatitis B vaccine-reactive T cell responses in failed humoral immunity |
| |
Mol Ther Methods Clin Dev. 2021 Mar 23;21:288-298. doi:10.1016/j.omtm.2021.03.012.eCollection 2021 Jun 11.
Gounwa Awad 1, Toralf Roch 1 2, Ulrik Stervbo 1, Sviatlana Kaliszczyk 1 2, Anna Stittrich 2 3, Jan Hörstrup 4, Ocan Cinkilic 5, Heiner Appel 6, Larysa Natrus 7, Ludmila Gayova 7, Felix Seibert 1, Frederic Bauer 1, Timm Westhoff 1, Mikalai Nienen 2 3 8, Nina Babel 1 2
|
|
| |
|
|
| |
| 180. | Clinical Significance of Quantitative e Antigen in a Cohort of Hepatitis B Virus Infected Children and Adults in North America |
| |
J Viral Hepat. 2021 Apr 24. doi: 10.1111/jvh.13520. Online ahead of print.
Stewart L Cooper 1, Wendy C King 2, Douglas B Mogul 3, Marc G Ghany 4, Kathleen B Schwarz 3, Hepatitis B Research Network (HBRN)
- Hepatitis B Research Network (HBRN):
Daryl T-Y Lau, Raymond T Chung, Lewis R Roberts, Mohamed A Hassan, Sarah Jane Schwarzenberg, Adrian M Di Bisceglie, Mauricio Lisker-Melman, Jeffrey Teckman, Harry L A Janssen, David K Wong, Joshua Juan, Jordan Feld, Colina Yim, Keyur Patel, Simon C Ling, William M Lee, Carol S Murakami, Robert Perrillo, Son Do, Norberto Rodriguez-Baez, Steven-Huy B Han, Tram T Tran, Norah A Terrault, Mandana Khalili, Philip Rosenthal, Anna Suk-Fong Lok, Robert J Fontana, Naoky Tsai, Barak Younoszai, Michael W Fried, Andrew Muir, Donna Evon, Jama M Darling, Robert C Carithers, Margaret Shuhart, Kris V Kowdley, Chia C Wang, Karen F Murray, Richard K Sterling, Velimir A Luketic, T Jake Liang, Jay H Hoofnagle, Edward Doo, Kyong-Mi Chang, Jang-June Park, Steven H Belle, Abdus Wahed, David Kleiner
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 187. | Clinical utility of quantifying hepatitis B surface antigen in African patients with chronic hepatitis B |
| |
J Viral Hepat. 2021 Mar 22. doi: 10.1111/jvh.13499. Online ahead of print.
Gerrit Post 1, Jess Howell 2, Amina Sow 3, Gibril Ndow 4, Isabelle Chemin 5, Gora Lo 3, Amie Cessay 4, Damien Cohen 5, Ramou Njie 6, Souleymane Toure 7, Madoky Diop 7, Roger Sombie 8, Jean Nana 9, Vincent Leroy 9, Karine Lacombe 10, Lamin Bojang 4, Frank Tacke 1, Coumba Toure-Kane 3, Mourtalla Ka 7, Maimuna Mendy 6, Souleymane Mboup 3, Mark Thursz 11, Yusuke Shimakawa 12, Patrick Ingiliz 1 13, Maud Lemoine 11
|
|
| |
| 188. | A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America |
| |
Hepatology. 2021 Mar 20. doi: 10.1002/hep.31823. Online ahead of print.
Richard K Sterling 1, Wendy C King 2, Mandana Khalili 3, Raymond T Chung 4, Mark Sulkowski 5, Mamta K Jain 6, Mauricio Lisker-Melman 7, Marc G Ghany 8, David K Wong 9, Amanda S Hinerman 2, Atul K Bhan 4, Abdus S Wahed 2, David E Kleiner 8, HIV-HBV Cohort Study of the Hepatitis B Research Network
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 192. | Multicenter Evaluation of the Cepheid Xpert ® HBV Viral Load Test |
| |
Diagnostics (Basel). 2021 Feb 12;11(2):297. doi: 10.3390/diagnostics11020297.
Fabbio Marcuccilli 1, Stephane Chevaliez 2, Thomas Muller 3, Luna Colagrossi 4, Giulia Abbondanza 1, Kurt Beyser 3, Mélanie Wlassow 2, Valérie Ortonne 2, Carlo Federico Perno 4, Marco Ciotti 1
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 198. | The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018 |
| |
Sex Transm Dis. 2021 Jan 23. doi: 10.1097/OLQ.0000000000001380. Online ahead of print.
Harrell W Chesson 1, Ian H Spicknall, Adrienna Bingham, Marc Brisson, Samuel T Eppink, Paul G Farnham, Kristen M Kreisel, Sagar Kumar, Jean-François Laprise, Thomas A Peterman, Henry Roberts, Thomas L Gift
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 204. | Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD) |
| |
NPJ Vaccines. 2021 Jan 11;6(1):9. doi: 10.1038/s41541-020-00266-4.
Shivali S Joshi 1, Rachelle P Davis 2, Mang M Ma 3, Edward Tam 4, Curtis L Cooper 5, Alnoor Ramji 6, Erin M Kelly 5, Saumya Jayakumar 1 7, Mark G Swain 1, Craig N Jenne 2, Carla S Coffin 8
|
|
| |
|
|
| |
|
|
| |
| 207. | Adherence to pregnancy hepatitis B care guidelines in women and infants in the and evaluation of two interventions to improve care: a multi-center hospital-based study |
| |
J Viral Hepat. 2020 Dec 29. doi: 10.1111/jvh.13459. Online ahead of print.
Tatyana Kushner 1, Elianna Kaplowitz 2, Rena Mei 3, Chelsea Xu 4, Alex Acker 5, Emma Rosenbluth 1, Igbagbosanmi Oredein 4, Monika Sarkar 4, Norah Terrault 6, Meena Bansal 1, Kimberly A Forde 7 8
|
|
| |
|
|
| |
| 209. | Screening for Hepatitis B Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement |
| |
JAMA. 2020 Dec 15;324(23):2415-2422. doi: 10.1001/jama.2020.22980.
US Preventive Services Task Force; Alex H Krist 1 2, Karina W Davidson 3, Carol M Mangione 4, Michael J Barry 5, Michael Cabana 6, Aaron B Caughey 7, Katrina Donahue 8, Chyke A Doubeni 9, John W Epling Jr 10, Martha Kubik 11, Gbenga Ogedegbe 12, Douglas K Owens 13, Lori Pbert 14, Michael Silverstein 15, Melissa A Simon 16, Chien-Wen Tseng 17 18, John B Wong 19
|
|
| |
|
|
| |
| 211. | New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings |
| |
J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):98-103. doi: 10.1097/QAI.0000000000002517.
David Dunn 1 2, Huw Price 1, Tobias Vudriko 3, Cissy Kityo 4, Godfrey Musoro 5, James Hakim 5, Charles Gilks 6, Pontiano Kaleebu 3, Deenan Pillay 7, Richard Gilson 1, DART Virology Group
|
|
| |
| 212. | Distinct Hepatitis B and HIV co-infected populations in Canada |
| |
J Viral Hepat. 2020 Dec 11. doi: 10.1111/jvh.13453. Online ahead of print.
Curtis Cooper 1, Matt Driedger 1, David Wong 2, Sarah Haylock-Jacobs 3, Abdel Aziz Shaheen 3, Carla Osiowy 4, Scott Fung 2, Karen Doucette 5, Alexander Wong 6, Lisa Barrett 7, Brian Conway 8, Alnoor Ramji 9, Gerald Minuk, Giada Sebastiani, Philip Wong, Carla S Coffin 3
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 218. | Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis |
| |
Drug Saf. 2020 Nov 3. doi: 10.1007/s40264-020-01014-2. Online ahead of print.
William R Treem 1, Melissa Palmer 2 3, Isabelle Lonjon-Domanec 4, Daniel Seekins 5, Lara Dimick-Santos 6, Mark I Avigan 6, John F Marcinak 7, Ajit Dash 8, Arie Regev 9, Eric Maller 10 11, Meenal Patwardhan 7, James H Lewis 12, Don C Rockey 13, Adrian M Di Bisceglie 14, James W Freston 15, Raul J Andrade 16, Naga Chalasani 17
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 225. | Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes |
| |
Open Forum Infect Dis. 2020 Aug 13;7(9):ofaa347. doi: 10.1093/ofid/ofaa347.eCollection 2020 Sep.
Zahid A Butt 1 2 3, Stanley Wong 2, Carmine Rossi 2, Mawuena Binka 2, Jason Wong 2 3, Amanda Yu 2, Maryam Darvishian 4, Maria Alvarez 2, Nuria Chapinal 4, Geoff Mckee 2, Mark Gilbert 2 3, Mark W Tyndall 3, Mel Krajden 2 3 5, Naveed Z Janjua 2 3
|
|
| |
|
|
| |
| 227. | A global investment framework for the elimination of hepatitis B |
| |
J Hepatol. 2020 Sep 21;S0168-8278(20)33625-4. doi: 10.1016/j.jhep.2020.09.013.Online ahead of print.
Jessica Howell 1, Alisa Pedrana 2, Sophia E Schroeder 2, Nick Scott 2, Lisa Aufegger 3, Rifat Atun 4, Ricardo Baptista-Leite 5, Gottfried Hirnschal 6, Ellen 't Hoen 7, Sharon J Hutchinson 8, Jeffrey V Lazarus 9, Lesi Olufunmilayo 10, Raquel Peck 11, Manik Sharma 12, Annette H Sohn 13, Alexander Thompson 14, Mark Thursz 15, David Wilson 2, Margaret Hellard 16
|
|
| |
|
|
| |
| 229. | medLow Incidence of Adverse Outcomes in Adults with Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy |
| |
Hepatology. 2020 Sep 16.doi: 10.1002/hep.31554. Online ahead of print.
Anna S Lok 1, Robert Perrillo 2, Christina M Lalama 3, Michael W Fried 4, Steven H Belle 5, Marc G Ghany 6, Mandana Khalili 7, Robert J Fontana 1, Richard K Sterling 8, Norah Terrault 9, Jordan J Feld 10, Adrian M Di Bisceglie 11, Daryl T Y Lau 12, Mohamed Hassan 13, Harry L A Janssen 14, Hepatitis B Research Network (HBRN)
Collaborators
- Hepatitis B Research Network (HBRN):
Raymond T Chung, Lewis R Roberts, Mauricio Lisker-Melman, David K Wong, Joshua Juan, Colina Yim, Keyur Patel, William M Lee, Carol S Murakami, Son Do, Steven-Huy B Han, Tram T Tran, Stewart L Cooper, Naoky Tsai, Barak Younoszai, Andrew Muir, Donna Evon, Jama M Darling, Robert C Carithers, Kris V Kowdley, Chia C Wang, Velimir A Luketic, T Jake Liang, Jay H Hoofnagle, Edward Doo, Kyong-Mi Chang, Jang-June Park, Abdus Wahed, Wendy C King, David Kleiner
|
|
| |
| 230. | Towards Genotype-Specific Care for Chronic Hepatitis B: The First 6 Years Follow Up From the CHARM Cohort Study |
| |
Open Forum Infect Dis. 2019 Nov 3;6(11):ofz469. doi: 10.1093/ofid/ofz469.eCollection 2019 Nov.
Jane Davies 1 2, Emma L Smith 2, Margaret Littlejohn 3, Rosalind Edwards 3, Vitina Sozzi 3, Kathy Jackson 3, Katie Mcguire 1, Paula Binks 1, Benjamin C Cowie 4 5, Stephen Locarnini 3, Joshua S Davis 1 6, Steven Y C Tong 1 7 8
|
|
| |
|
|
| |
|
|
| |
| 233. | Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions - a prospective descriptive study |
| |
Int J Infect Dis. 2020 Aug 27;S1201-9712(20)30689-5. doi: 10.1016/j.ijid.2020.08.059.Online ahead of print.
Claire Kelly 1, Marinos Pericleous 1, Ayesha Ahmed 2, Tushna Vandrevala 3, Jane Hendy 2, Shuja Shafi 4, Simon Skene 5, Sumita Verma 6, Chantal Edge 7, Margot Nicholls 8, Charles Gore 9, Simon de Lusignan 10, Aftab Ala 11
|
|
| |
| 234. | Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis |
| |
Aliment Pharmacol Ther. 2020 Sep 4. doi: 10.1111/apt.16067. Online ahead of print.
Milan J Sonneveld 1, Willem P Brouwer 1, Bettina E Hansen 2, Henry L-Y Chan 3, Teerha Piratvisuth 4, Ji-Dong Jia 5, Stefan Zeuzem 6, Rong-Nan Chien 7, Hannah Choi 2, Robert J de Knegt 1, Cynthia Wat 8, Vedran Pavlovic 8, Anuj Gaggar 9, Qing Xie 10, Maria Buti 11, Robert A de Man 1, Harry L A Janssen 1 2, SONIC-B Study Group
|
|
| |
| 235. | Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection |
| |
Clin Infect Dis. 2020 Sep 1;ciaa1303. doi: 10.1093/cid/ciaa1303. Online ahead of print.
Mandana Khalili 1, Wendy C King 2, David E Kleiner 3, Mamta K Jain 4, Raymond T Chung 5, Mark Sulkowski 6, Mauricio Lisker-Melman 7, David K Wong 8, Marc Ghany 3, Arun Sanyal 9, Richard K Sterling 9, HIV-HBV Cohort Study of the Hepatitis B Research Network
|
|
| |
| 236. | Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS) |
| |
Transfusion. 2020 Aug 31. doi: 10.1111/trf.16005. Online ahead of print.
Whitney R Steele 1, Roger Y Dodd 1, Edward P Notari 1, Meng Xu 1, Diane Nelson 1, Debra A Kessler 2, Rita Reik 3, Alan E Williams 4, Brian Custer 5, Susan L Stramer 1, Transfusion-Transmissible Infections Monitoring System (TTIMS)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 240. | Susceptibility to Hepatitis A and B Virus Among Clients at a Syringe Services Program in Philadelphia, 2018 |
| |
Public Health Rep. 2020 Aug 13;33354920943528. doi: 10.1177/0033354920943528.Online ahead of print.
Mary Figgatt 1, Jack Hildick-Smith 1, Eman Addish 1, Jennie Coleman 2, José Benitez 2, Catherine Freeland 3, Steven Alles 1, Kendra Viner 1, Caroline Johnson 1, Danica Kuncio 1
|
|
| |
| 241. | New blood borne virus infections among organ transplant recipients: an Australian data-linked cohort study examining donor-transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015 |
| |
Transpl Infect Dis. 2020 Aug 7;e13437. doi: 10.1111/tid.13437. Online ahead of print.
Karen Mj Waller 1, Nicole L De La Mata 1, James A Hedley 1, Brenda M Rosales 1 2, Michael J O'Leary, Elena Cavazzoni 3, Vidiya Ramachandran 4, William D Rawlinson 4 5, Patrick J Kelly 1, Kate R Wyburn 2 6, Angela C Webster 1 7
|
|
| |
|
|
| |
| 243. | Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation |
| |
Hepatology. 2020 Aug 2. doi: 10.1002/hep.31491. Online ahead of print.
Elizabeth C Verna 1, Marina Serper 2, Jaime Chu 3, Kathleen Corey 4, Oren K Fix 5, Karen Hoyt 6, Kimberly A Page 7, Rohit Loomba 8, Ming Li 9, Gregory T Everson 10, Michael W Fried 11, Guadalupe Garcia-Tsao 12, Norah Terrault 9, Anna S Lok 13, Raymond T Chung 4, K Rajender Reddy 2
|
|
| |
| 244. | Hepatitis B Virus Mutant Infections in Hemodialysis Patients: A Case Series |
| |
Kidney Med. 2019 Oct 1;1(6):347-353. doi: 10.1016/j.xkme.2019.07.011.eCollection Nov-Dec 2019.
Ibironke W Apata 1 2, Duc B Nguyen 1, Yury Khudyakov 1, Tonya Mixson-Hayden 1, Jon Rosenberg 3, Matt Zahn 4, Jane Greenko 5, Ernest Clement 6, Allison E Portney 7 8, Prathit A Kulkarni 1 7, Maura Comer 9, Eleanor Adams 10, Saleem Kamili 1, Priti R Patel 1, Anne C Moorman 1
|
|
| |
|
|
| |
| 246. | Progress towards elimination goals for viral hepatitis |
| |
Nat Rev Gastroenterol Hepatol. 2020 Jul 23;1-10. doi: 10.1038/s41575-020-0332-6.Online ahead of print.
Andrea L Cox 1, Manal H El-Sayed 2, Jia-Horng Kao 3 4, Jeffrey V Lazarus 5, Maud Lemoine 6, Anna S Lok 7, Fabien Zoulim 8 9 10
|
|
| |
| 247. | Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide |
| |
Dig Liver Dis. 2020 Jul 20;S1590-8658(20)30322-4. doi: 10.1016/j.dld.2020.06.037.Online ahead of print.
Luisa Roade 1, Alessandro Loglio 2, Marta Borghi 2, Mar Riveiro-Barciela 1, Roberta Soffredini 2, Floriana Facchetti 2, Dhanai di Paolo 2, David Tabernero 3, Giovanna Lunghi 4, Rafael Esteban 1, Maria Buti 5, Pietro Lampertico 6
|
|
| |
|
|
| |
|
|
| |
| 250. | Hepatitis B seroprevalence in the U.S. military and its impact on potential screening strategies |
| |
Mil Med. 2020 Jul 10;usaa131. doi: 10.1093/milmed/usaa131. Online ahead of print.
Paul T Scott 1, Robert L Cohen 2 3, David M Brett-Major 4, Shilpa Hakre 1 5, Jennifer A Malia 1, Jason F Okulicz 6, Charmagne G Beckett 7, Jason M Blaylock 8, Michael A Forgione 6, Stephen A Harrison 6, Clinton K Murray 6, Francisco J Rentas 9, Roland L Fahie 9, Adam W Armstrong 10, Aatif M Hayat 2, Laura A Pacha 2 11, Peter Dawson 12, Beth Blackwell 12, Angelia A Eick-Cost 13 14, Hala H Maktabi 13 15, Nelson L Michael 1, Linda L Jagodzinski 1, Steven B Cersovsky 2, Sheila A Peel 1
|
|
| |
|
|
| |
| 252. | ATI-2173, A Novel Liver-Targeted Non-Chain Terminating Nucleotide for HBV Cure Regimens |
| |
Antimicrob Agents Chemother. 2020 Jun 15;AAC.00836-20. doi: 10.1128/AAC.00836-20.Online ahead of print.
Katherine E Squires 1, Douglas L Mayers 1, Gregory R Bluemling 2, Alexander A Kolykhalov 2, David B Guthrie 2, Prabhakar Reddy 2, Debbie G Mitchell 2, Manohar T Saindane 2, Zachary M Sticher 2, Vindhya Edpuganti 2, Abel De La Rosa 1
|
|
| |
| 253. | Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020 |
| |
MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.
Jefferson M Jones, Ian Kracalik, Marilyn E Levi, James S Bowman 3rd, James J Berger, Danae Bixler, Kate Buchacz, Anne Moorman, John T Brooks, Sridhar V Basavaraju
|
|
| |
|
|
| |
|
|
| |
| 256. | Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic HBV Infection: Systematic Review and Meta-analysis |
| |
Clin Gastroenterol Hepatol. 2020 May 27;S1542-3565(20)30748-5.doi: 10.1016/j.cgh.2020.05.041. Online ahead of print.
Ryan T Anderson 1, Hannah S J Choi 2, Oliver Lenz 3, Marion G Peters 4, Harry L A Janssen 5, Poonam Mishra 6, Eric Donaldson 7, Gabriel Westman 8, Stephanie Buchholz 9, Veronica Miller 10, Bettina E Hansen 11
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 265. | Vitamin D and the Hepatitis B Vaccine Response: A Prospective Cohort Study and a Randomized, Placebo-Controlled Oral Vitamin D 3 and Simulated Sunlight Supplementation Trial in Healthy Adults |
| |
Nutr. 2020 May 10.doi: 10.1007/s00394-020-02261-w. Online ahead of print
Daniel S Kashi 1 2, Samuel J Oliver 3, Laurel M Wentz 4, Ross Roberts 1, Alexander T Carswell 1, Jonathan C Y Tang 5, Sarah Jackson 6, Rachel M Izard 7, Donald Allan 8, Lesley E Rhodes 9, William D Fraser 5, Julie P Greeves 5 6, Neil P Walsh 2
|
|
| |
|
|
| |
|
|
| |
| 268. | Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data |
| |
Clin Gastroenterol Hepatol. 2020 Apr 29;S1542-3565(20)30590-5.doi: 10.1016/j.cgh.2020.04.045. Online ahead of print.
Kyoko Yoshida 1, Alice Desbiolles 2, Sarah F Feldman 2, Sang Hoon Ahn 3, Enagnon K Alidjinou 4, Masanori Atsukawa 5, Laurence Bocket 4, Maurizia R Brunetto 6, Maria Buti 7, Ivana Carey 8, Gian Paolo Caviglia 9, En-Qiang Chen 10, Markus Cornberg 11, Masaru Enomoto 12, Masao Honda 13, Christoph Höner Zu Siederdissen 11, Masatoshi Ishigami 14, Harry LA Janssen 15, Benjamin Maasoumy 11, Takeshi Matsui 16, Akihiro Matsumoto 17, Shuhei Nishiguchi 18, Mar Riveiro-Barciela 7, Akinobu Takaki 19, Pisit Tangkijvanich 20, Hidenori Toyoda 21, Margo Jh van Campenhout 22, Bo Wang 8, Lai Wei 23, Hwai-I Yang 24, Yoshihiko Yano 25, Hiroshi Yatsuhashi 26, Man-Fung Yuen 27, Eiji Tanaka 28, Maud Lemoine 1, Yasuhito Tanaka 29, Yusuke Shimakawa 30
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 272. | Hbsag Levels Can Be Used to Rule Out Cirrhosis in Hbeag Positive Chronic Hepatitis B: Results From the Sonic-B Study |
| |
J Infect Dis. 2020 Apr 21;jiaa192 doi: 10.1093/infdis/jiaa192. Online ahead of print.
Milan J Sonneveld 1, Bettina E Hansen 2 3, Willem P Brouwer 1, Henry L-Y Chan 4, Teerha Piratvisuth 5, Ji-Dong Jia 6, Stefan Zeuzem 7, R N Chien 8, R J de Knegt 1, Cynthia Wat 9, Vedran Pavlovic 9, Anuj Gaggar 10, Qing Xie 11, Maria Buti 12, R A de Man 1, Harry L A Janssen 1 2, SONIC-B Study group
|
|
| |
| 273. | Hepatitis B Virus Seroepidemiology Data for Africa: Modelling Intervention Strategies Based on a Systematic Review and Meta-Analysis |
| |
PLoS Med. 2020 Apr 21;17(4):e1003068. doi: 10.1371/journal.pmed.1003068.eCollection 2020 Apr.
Anna L McNaughton 1, José Lourenço 2, Phillip Armand Bester 3, Jolynne Mokaya 1, Sheila F Lumley 1 4, Uri Obolski 5 6, Donall Forde 7, Tongai G Maponga 8, Kenneth R Katumba 9, Dominique Goedhals 3, Sunetra Gupta 2, Janet Seeley 9 10, Robert Newton 9 11, Ponsiano Ocama 12, Philippa C Matthews 1 4
|
|
| |
|
|
| |
|
|
| |
| 276. | Final Analysis of the International Observational S-Collate Study of Peginterferon alfa-2a in Patients With Chronic Hepatitis B |
| |
PloS One. 2020 Apr 10;15(4):e0230893. doi: 10.1371/journal.pone.0230893. eCollection 2020.
Patrick Marcellin 1, Qing Xie 2, Seung Woon Paik 3, Robert Flisiak 4, Teerha Piratvisuth 5, Jörg Petersen 6, Tarik Asselah 1, Markus Cornberg 7, Denis Ouzan 8, Graham R Foster 9, Georgios Papatheodoridis 10, Diethelm Messinger 11, Loredana Regep 12, Georgios Bakalos 13, Ulrich Alshuth 14, Pietro Lampertico 15, Heiner Wedemeyer 7
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 280. | Hepatic Histology in Treatment-naïve Children With Chronic Hepatitis B Infection Living in the United States and Canada |
| |
Rodriguez-Baez N1, Murray KF2, Kleiner DE3, Ling SC4, Rosenthal P5, Carlin K6, Cooper K6, Schwarz KB7, Schwarzenberg SJ8, Teckman JH9, Ghany MG10, Alawad A10. J Pediatr Gastroenterol Nutr. 2020 Apr 3. doi: 10.1097/MPG.0000000000002712. [Epub ahead of print]
|
|
| |
| 281. | Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey |
| |
Mukhtar NA1, Evon DM2, Yim C3, Lok AS4, Lisha N5, Lisker-Melman M6, Hassan M7, Janssen HLA3, Khalili M8. Dig Dis Sci. 2020 Apr 1. doi: 10.1007/s10620-020-06224-3. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 288. | Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease |
| |
Chan TT1, Chan WK2, Wong GL1,3, Chan AW4, Nik Mustapha NR5, Chan SL6, Chong CC7, Mahadeva S2, Shu SS1,3, Lai PB7, Chan HL1,3, Wong VW1,3. Am J Gastroenterol. 2020 Mar 9. doi: 10.14309/ajg.0000000000000588. [Epub ahead of print]
|
|
| |
| 289. | A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B |
| |
Chen Y1,2, Cao D2, Li C1,2, Zhang P1,2, Wang X1, Li N1, Han Q1, Liu Z1. Eur J Gastroenterol Hepatol. 2020 Feb 27. doi: 10.1097/MEG.0000000000001691. [Epub ahead of print]
|
|
| |
| 290. | Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America |
| |
Brahmania M1, Liu S2, Wahed AS3, Yim C1, Hansen BE4, Khalili M5, Terrault NA5, Lok AS6, Ghany M7, Wang J2, Wong D1, Janssen HLA8; Hepatitis B Research Network. Ann Hepatol. 2020 Feb 8. pii: S1665-2681(20)30009-0. doi: 10.1016/j.aohep.2020.01.005. [Epub ahead of print]
|
|
| |
| 291. | No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic HBV Infection Treated With Entecavir vs Tenofovir |
| |
Oh H1, Yoon EL2, Jun DW3, Ahn SB4, Lee HY4, Jeong JY5, Kim HS6, Jeong SW7, Kim SE8, Shim JJ9, Sohn JH10, Cho YK11; Long-term Safety of Entecavir and Tenofovir in Patients with Treatment-naive Chronic Hepatitis B virus (CHB) Infection (SAINT) study. Clin Gastroenterol Hepatol. 2020 Mar 2. pii: S1542-3565(20)30265-2. doi: 10.1016/j.cgh.2020.02.046. [Epub ahead of print]
|
|
| |
| 292. | Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis |
| |
Harigai M1, Winthrop K2, Takeuchi T3, Hsieh TY4, Chen YM4, Smolen JS5, Burmester G6, Walls C7, Wu WS7, Dickson C7, Liao R7, Genovese MC8. RMD Open. 2020 Feb;6(1). pii: e001095. doi: 10.1136/rmdopen-2019-001095
|
|
| |
| 293. | Antiviral therapy and hepatocellular carcinoma risk in hepatitis B patients with cirrhosis |
| |
Gao X1,2, Yang HI3, Trinh H4, Jeong D1, Li J5, Zhang J6, Le A1, Hoang J1, Nguyen P1, Henry L1, Nguyen MH1. Eur J Gastroenterol Hepatol. 2019 Dec 24. doi: 10.1097/MEG.0000000000001639.
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 311. | Durability of Hepatitis B Surface Antigen Loss With Nucleotide Analogue and Peginterferon Therapy in Patients With Chronic Hepatitis B |
| |
Lok AS1, Zoulim F2, Dusheiko G3, Chan HLY4, Buti M5, Ghany MG6, Gaggar A7, Yang JC7, Wu G7, Flaherty JF7, Subramanian GM7, Locarnini S8, Marcellin P9. Hepatol Commun. 2019 Oct 10;4(1):8-20. doi: 10.1002/hep4.1436. eCollection 2020 Jan.
|
|
| |
| 312. | Hepatitis B virus RNA as Early Predictor for Response to PEGylated Interferon Alfa in HBeAg Negative Chronic Hepatitis B |
| |
Farag MS1,2, van Campenhout MJH3, Pfefferkorn M4, Fischer J4, Deichsel D4, Boonstra A3, van Vuuren AJ3, Ferenci P5, Feld JJ1, Berg T4, Hansen BE1,6, van Bömmel F4, Janssen HLA1. Clin Infect Dis. 2020 Jan 8. pii: ciaa013. doi: 10.1093/cid/ciaa013. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 315. | Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis |
| |
Li M1, Lv T2, Wu S1, Wei W1, Wu X3, Ou X2, Ma H2, Chow SC4, Kong Y5, You H6, Jia J7. Hepatol Int. 2020 Jan 3. doi: 10.1007/s12072-019-10005-0. [Epub ahead of print]
|
|
| |
| 316. | Enhancing the hepatitis B care cascade in Australia: A cost-effectiveness model |
| |
Xiao Y1,2,3, Howell J1,2,3,4, van Gemert C1,3, Thompson AJ2,3, Seaman CP1,4, McCulloch K3,5,6,7, Scott N1,4, Hellard ME1,3,4,7,8,9. J Viral Hepat. 2019 Dec 19. doi: 10.1111/jvh.13252. [Epub ahead of print]
|
|
| |
| 317. | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission |
| |
Sarin SK1, Kumar M2, Eslam M3, George J3, Al Mahtab M4, Akbar SMF5, Jia J6, Tian Q6, Aggarwal R7, Muljono DH8, Omata M9, Ooka Y10, Han KH11, Lee HW11, Jafri W12, Butt AS12, Chong CH13, Lim SG14, Pwu RF15, Chen DS16. Lancet Gastroenterol Hepatol. 2019 Dec 13. pii: S2468-1253(19)30342-5. doi: 10.1016/S2468-1253(19)30342-5. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 320. | Role of Biomarkers in Guiding Cure of Viral Hepatitis B |
| |
Buti M1,2, Riveiro-Barciela M1,2, Rodríguez-Frías F2,3,4, Tabernero D2,3, Esteban R1,2. Semin Liver Dis. 2019 Dec 5. doi: 10.1055/s-0039-3401031. [Epub ahead of print]
|
|
| |
| 321. | Role of Biomarkers in Guiding Cure of Viral Hepatitis B |
| |
Buti M1,2, Riveiro-Barciela M1,2, Rodríguez-Frías F2,3,4, Tabernero D2,3, Esteban R1,2. Semin Liver Dis. 2019 Dec 5. doi: 10.1055/s-0039-3401031. [Epub ahead of print]
|
|
| |
| 322. | Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers |
| |
Mahfouz M1, Nguyen H2, Tu J3, Diaz CR4,5, Anjan S6, Brown S4, Bosire K7, Carrasquillo O4,8, Martin P8,9, Jones PD10,11. Dig Dis Sci. 2019 Dec 7. doi: 10.1007/s10620-019-05980-1. [Epub ahead of print]
|
|
| |
| 323. | Liver safety assessment in clinical trials of new agents for chronic hepatitis B |
| |
Fontana RJ1, Avigan MI2, Janssen HLA3, Regev A4, Mishra P5, Gaggar A6, Brown N7, Wat C8, Mendez P9, Anderson RT10, Given B11, Miller V10, Beumont M12. J Viral Hepat. 2019 Dec 11. doi: 10.1111/jvh.13223. [Epub ahead of print]
|
|
| |
|
|
| |
| 325. | Long-term virological and adherence outcomes to antiviral treatment in a 4-year cohort chronic HBV study |
| |
Abreu RM1,2, Bassit LC3, Tao S3, Jiang Y3, Ferreira AS1, Hori PC2, Ganova-Raeva LM4, Khudyakov Y4, Schinazi RF3, Carrilho FJ1, Ono SK1. Antivir Ther. 2019 Dec 4. doi: 10.3851/IMP3338. [Epub ahead of print]
|
|
| |
| 326. | Incidence and Risk Factors of Postoperative Mortality and Morbidity After Elective Versus Emergent Abdominal Surgery in a National Sample of 8193 Patients With Cirrhosis |
| |
Johnson KM1,2, Newman KL3, Green PK4, Berry K4, Cornia PB1,2, Wu P5, Beste LA4,6,2, Itani K7, Harris AHS8,9, Kamath PS10, Ioannou GN4,11. Ann Surg. 2019 Oct 23. doi: 10.1097/SLA.0000000000003674. [Epub ahead of print]
|
|
| |
|
|
| |
| 328. | Point of care and oral fluid Hepatitis B testing in remote Indigenous communities of northern Australia |
| |
Sullivan RP1,2,3, Davies J1,2, Binks P1, Dhurrkay RG1, Gurruwiwi GG1, Bukulatjpi SM1, McKinnon M1, Hosking K1,4, Littlejohn M5, Jackson K5, Locarnini S5, Davis JS1,6, Tong SY1,7. J Viral Hepat. 2019 Nov 29. doi: 10.1111/jvh.13243. [Epub ahead of print]
|
|
| |
| 329. | Asian Consensus Recommendations on Optimizing the Diagnosis and Initiation of Treatment of Hepatitis B Virus Infection in Resource-Limited Settings |
| |
Gane EJ1, Charlton MR2, Mohamed R3, Sollano JD4, Tun KS5, Thuy PTT6, Payawal DA7, Gani RA8, Muljono DH9,10,11, Acharya SK12, Zhuang H13, Shukla A14, Madan K15, Saraf N16, Tyagi S17, Singh KR18, Cua IHY19, Jargalsaikhan G20,21, Duger D22, Sukeepaisarnjaroen W23, Purnomo HD24, Hasan I25, Lesmana LA26, Lesmana CRA27, Kyi KP28, Naing W29, Ac R30, Hadigal S30. J Viral Hepat. 2019 Nov 30. doi: 10.1111/jvh.13244. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 334. | RNA Interference Therapy with ARC-520 Results in Prolonged HBsAg Response in Patients with Chronic Hepatitis B Infection |
| |
Yuen MF1, Schiefke I2, Yoon JH3, Ahn SH4, Heo J5, Kim JH6, Chan HLY7, Yoon KT8, Klinker H9, Manns M10, Petersen J11, Schluep T12, Hamilton J12, Given BD12, Ferrari C13, Lai CL1, Locarnini SA14, Gish RG15. Hepatology. 2019 Oct 26. doi: 10.1002/hep.31008. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 337. | 'Teach-back' is a simple communication tool that improves disease knowledge in people with chronic hepatitis B - a pilot randomized controlled study |
| |
Tran S1,2, Bennett G3,4, Richmond J3,4,5, Nguyen T3,4, Ryan M3,4, Hong T3,4, Howell J3,4, Demediuk B3,4, Desmond P3,4, Bell S3,4, Thompson A6,7. BMC Public Health. 2019 Oct 23;19(1):1355. doi: 10.1186/s12889-019-7658-4.
|
|
| |
|
|
| |
| 339. | Long-term Outcomes with Oral Therapy in Liver Transplant Recipients with Hepatitis B |
| |
Saab S1,2,3, Song D2, Challita YP1, Zhou TX1, Saab EG1, Viramontes MR1, Choi G1,2, Durazo FA1,2, Han SB1,2, El Kabany MM1,2, Jackson NJ4, Busuttil RW1. Clin Transplant. 2019 Oct 25:e13740. doi: 10.1111/ctr.13740. [Epub ahead of print]
|
|
| |
| 340. | National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2018 |
| |
Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, Singleton JA, Stokley S. MMWR Morb Mortal Wkly Rep. 2019 Aug 23;68(33):718-723. doi: 10.15585/mmwr.mm6833a2.
|
|
| |
|
|
| |
| 342. | HIV and the liver |
| |
Sherman KE1, Peters MG2, Thomas DL3. Top Antivir Med. 2019 Sep/Oct;27(3):101-110.
|
|
| |
| 343. | Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis |
| |
Platt L1, French CE2, McGowan CR1,3, Sabin K4, Gower E5, Trickey A2, McDonald B6,7, Ong J7, Stone J2, Easterbrook P8, Vickerman P2. J Viral Hepat. 2019 Oct 11. doi: 10.1111/jvh.13217. [Epub ahead of print]
|
|
| |
|
|
| |
| 345. | Hepatitis B virus reactivation: Risk factors and current management strategies |
| |
Smalls DJ1, Kiger RE1, Norris LB1,2, Bennett CL1,2,3,4,5, Love BL1,2,3. Pharmacotherapy. 2019 Oct 9. doi: 10.1002/phar.2340. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 351. | Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort |
| |
Schwarz KB1, Lombardero M2, Di Bisceglie AM3, Murray KF4, Rosenthal P5, Ling SC6, Cloonan YK2, Rodriguez-Baez N7, Schwarzenberg SJ8, Hoofnagle JH9, Teckman J3; Hepatitis B Research Network (HBRN). J Pediatr Gastroenterol Nutr. 2019 Aug 20. doi: 10.1097/MPG.0000000000002467. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 358. | Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort |
| |
Schwarz KB1, Lombardero M2, Di Bisceglie AM3, Murray KF4, Rosenthal P5, Ling SC6, Cloonan YK2, Rodriguez-Baez N7, Schwarzenberg SJ8, Hoofnagle JH9, Teckman J3; Hepatitis B Research Network (HBRN). J Pediatr Gastroenterol Nutr. 2019 Aug 20. doi: 10.1097/MPG.0000000000002467. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 362. | Modelling progress towards elimination of hepatitis B in Australia |
| |
McCulloch K1,2, Romero N1,3, MacLachlan J1,3, Allard N1,3, Cowie B1,3,4. Hepatology. 2019 Aug 16. doi: 10.1002/hep.30899. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 365. | Predicting HBsAg clearance in genotype A chronic hepatitis B using HBsAg epitope profiling: a biomarker for functional cure |
| |
Walsh R1, Hammond R1, Yuen L1, Deerain J1, O'Donnell T1, Leary T2, Cloherty G2, Gaggar A3, Kitrinos K3, Subramanian M3, Wong D4, Locarnini S1.
Liver Int. 2019 Aug 4. doi: 10.1111/liv.14207. [Epub ahead of print]
|
|
| |
| 366. | Prevalence of Hepatitis B Virus Exposure in the Veterans Health Administration and Association With Military-related Risk Factors |
| |
Beste LA1, Ioannou GN2, Chang MF3, Forsberg CW4, Korpak AM4, Boyko EJ5, Sporleder JL6, Smith NL7, Maynard C8, Chartier M9, Dominitz JA10; VA Cooperative Study Group #488. Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30845-6. doi: 10.1016/j.cgh.2019.07.056. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 369. | Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy |
| |
Fan R1, Zhou B1, Xu M2, Tan D3, Niu J4, Wang H5, Ren H6, Chen X7, Wang M8, Ning Q9, Shi G10, Sheng J11, Tang H12, Bai X13, Liu S1, Lu F14, Peng J1, Sun J15, Xie Q16, Hou J17; Chronic Hepatitis B Study Consortium.Collaborators (9) Clin Gastroenterol Hepatol. 2019 Jul 27. pii: S1542-3565(19)30790-6. doi: 10.1016/j.cgh.2019.07.046. [Epub ahead of print]
|
|
| |
|
|
| |
| 371. | Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement |
| |
US Preventive Services Task Force, Owens DK1,2, Davidson KW3, Krist AH4,5, Barry MJ6, Cabana M7, Caughey AB8, Doubeni CA9, Epling JW Jr10, Kemper AR11, Kubik M12, Landefeld CS13, Mangione CM14, Pbert L15, Silverstein M16, Simon MA17, Tseng CW18,19, Wong JB20. JAMA. 2019 Jul 23;322(4):349-354. doi: 10.1001/jama.2019.9365.
|
|
| |
|
|
| |
| 373. | Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers |
| |
Chang KC1, Chang MH1, Lee CN1, Chang CH1, Wu JF1, Ni YH1, Wen WH2, Shyu MK1, Lai MW3, Chen SM1, Hu JJ1, Lin HH2, Hsu JJ1, Mu SC1, Lin YC2, Liu CJ1, Chen DS1, Lin LH1, Chen HL1; Taiwan Study Group for the Prevention of Mother-to-Infant Transmission of HBV (PreMIT study). Aliment Pharmacol Ther. 2019 Aug;50(3):306-316. doi: 10.1111/apt.15321. Epub 2019 Jul 4.
|
|
| |
| 374. | Challenges with hepatitis B vaccination of high risk adults - A pilot program |
| |
Bridges CB1, Watson TL2, Nelson NP3, Chavez-Torres M4, Fineis P5, Ntiri-Reid B6, Wake E7, Leahy JM8, Kurian AK9, Hall MAK10, Kennedy ED11. Vaccine. 2019 Jul 11. pii: S0264-410X(19)30746-7. doi: 10.1016/j.vaccine.2019.05.089. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 380. | Screening and Prophylaxis to Prevent Hepatitis B Reactivation: Other Populations and Newer Agents |
| |
Sasadeusz J1, Grigg A2, Hughes PD3, Lee Lim S4, Lucas M5, McColl G6, McLachlan SA7, Peters MG8, Shackel N9, Slavin M10, Sundararajan V11, Thompson A12, Doyle J13, Rickard J2, De Cruz P14, Gish RG15, Visvanathan K12. Clin Liver Dis. 2019 Aug;23(3):521-534. doi: 10.1016/j.cld.2019.04.012. Epub 2019 Jun 5.
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 388. | Evaluating non-invasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV coinfected adults |
| |
Sterling RK1, King WC2, Wahed AS2, Kleiner DE3, Khalili M4, Sulkowski M5, Chung RT6, Jain MK7, Lisker-Melman M8, Wong DK9, Ghany MG3; HIV-HBV Cohort Study of the Hepatitis B Research Network. Hepatology. 2019 Jun 20. doi: 10.1002/hep.30825. [Epub ahead of print]
|
|
| |
| 389. | Exploration of long-acting implant formulations of hepatitis B drug entecavir |
| |
Henry SJ1, Barrett SE2, Forster SP1, Teller RS1, Yang Z1, Li L1, Mackey MA1, Doto GJ3, Ruth MP3, Tsuchiya T3, Klein LJ1, Gindy ME1. Eur J Pharm Sci. 2019 Jun 15;136:104958. doi: 10.1016/j.ejps.2019.104958. [Epub ahead of print]
|
|
| |
| 390. | Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015 |
| |
Roberts H1, Boktor SW2, Waller K2, Daar ZS3, Boscarino JA3, Dubin PH1,4, Suryaprasad A1,5, Moorman AC1. PLoS One. 2019 Jun 6;14(6):e0217455. doi: 10.1371/journal.pone.0217455. eCollection 2019.
|
|
| |
| 391. | Patient-Reported Outcomes in Patients Chronic Viral Hepatitis without Cirrhosis: The Impact of Hepatitis B and C Viral Replication |
| |
Younossi ZM1,2, Stepanova M3, Younossi I3, Papatheodoridis G4, Janssen HLA5, Agarwal K6, Nguyen MH7, Gane E8, Tsai N9, Nader F3. Liver Int. 2019 Jun 7. doi: 10.1111/liv.14171. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 394. | Associations Between Hepatitis B Virus Infection and Risk of All Cancer Types |
| |
Song C1, Lv J2, Liu Y3, Chen JG4, Ge Z1, Zhu J4, Dai J1, Du LB5, Yu C2, Guo Y6, Bian Z6, Yang L6,7, Chen Y6,7, Chen Z6,7, Liu J8, Jiang J9, Zhu L9, Zhai X9, Jiang Y1, Ma H1, Jin G1, Shen H1, Li L2, Hu Z1; China Kadoorie Biobank Collaborative Group. JAMA Netw Open. 2019 Jun 5;2(6):e195718. doi: 10.1001/jamanetworkopen.2019.5718.
|
|
| |
| 395. | Ten-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis Bvirus infection |
| |
Marcellin P1, Wong D2, Sievert W3, Buggisch P4, Petersen J4, Flisiak R5, Manns M6,7, Kaita K8, Krastev Z9, Lee SS10, Cathcart AL11, Crans G11, Op den Brouw M12, Jump B11, Gaggar A11, Flaherty J11, Buti-Ferret M13. Liver Int. 2019 May 28. doi: 10.1111/liv.14155. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 398. | Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients |
| |
Lo Re V 3rd1, Newcomb CW1, Carbonari DM1, Roy JA1, Althoff KN2, Kitahata MM3, Reddy KR1, Lim JK4, Silverberg MJ5, Mayor AM6, Horberg MA7, Cachay ER8, Kirk GD2, Hull M9, Gill J10, Sterling TR11, Kostman JR12, Peters MG13, Moore RD2, Klein MB14, Kim HN3; North American AIDS Cohort Collaboration on Research and Design of IeDEA. J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002094. [Epub ahead of print]
|
|
| |
|
|
| |
| 400. | Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells |
| |
Dias J1, Hengst J2, Parrot T1, Leeansyah E3, Lunemann S4, Malone DFG1, Hardtke S5, Strauss O1, Zimmer CL1, Berglin L1, Schirdewahn T5, Ciesek S6, Marquardt N1, von Hahn T5, Manns MP5, Cornberg M5, Ljunggren HG1, Wedemeyer H7, Sandberg JK1, Björkström NK8. J Hepatol. 2019 May 6. pii: S0168-8278(19)30270-3. doi: 10.1016/j.jhep.2019.04.009. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 406. | A global scientific strategy to cure hepatitis B |
| |
Revill PA1, Chisari FV2, Block JM3, Dandri M4, Gehring AJ5, Guo H6, Hu J7, Kramvis A8, Lampertico P9, Janssen HLA10, Levrero M11, Li W12, Liang TJ13, Lim SG14, Lu F15, Penicaud MC16, Tavis JE17, Thimme R18; Members of the ICE-HBV Working Groups; ICE-HBV Stakeholders Group Chairs; ICE-HBV Senior Advisors, Zoulim F19. Lancet Gastroenterol Hepatol. 2019 Apr 10. pii: S2468-1253(19)30119-0. doi: 10.1016/S2468-1253(19)30119-0. [Epub ahead of print]
|
|
| |
|
|
| |
| 408. | Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection |
| |
Post G1,2, Shalev N3, Baumgarten A2, Shimakawa Y4, Lemoine M5, Krznaric I2, Dupke S2, Carganico A2, Arastéh K6, Ingiliz P2. Eur J Gastroenterol Hepatol. 2019 Apr 5. doi: 10.1097/MEG.0000000000001409. [Epub ahead of print]
|
|
| |
|
|
| |
| 410. | Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus |
| |
Salvadori N1,2, Fan B3, Teeyasoontranon W4, Ngo-Giang-Huong N1,2,5, Phanomcheong S6, Luvira A7, Puangsombat A8, Suwannarat A9, Srirompotong U10, Putiyanun C11, Cressey TR1,2,5,12, Decker L1,2, Khamduang W2, Harrison L13, Tierney C13, Shepherd JA3,14, Kourtis AP15, Bulterys M15,16, Siberry GK17, Jourdain G1,2,5. Clin Infect Dis. 2019 Mar 29. pii: ciy982. doi: 10.1093/cid/ciy982. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| 413. | Age, race and viral genotype are associated with the prevalence of Hepatitis B e antigen in children and adults with chronic Hepatitis B |
| |
Di Bisceglie AM1, King WC2, Lisker-Melman M3, Khalili M4, Belle SH2, Feld JJ5, Ghany MG6, Janssen HLA5, Lau D7, Lee WM8, Ling SC5, Cooper S9, Rosenthal P4, Schwarz KB10, Sterling RK11, Teckman JH1, Terrault N4; Hepatitis B Research Network (HBRN). J Viral Hepat. 2019 Apr 11. doi: 10.1111/jvh.13104. [Epub ahead of print]
Collaborators (37)
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
| 418. | Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B |
| |
Lee TY1,2, Hsu YC3,4,5,6, Tseng HC7, Yu SH1, Lin JT4,8, Wu MS9, Wu CY7,10,11,12. JAMA Intern Med. 2019 Mar 18. doi: 10.1001/jamainternmed.2018.8342. [Epub ahead of print]
|
|
| |
|
|
| |
|
|
| |
| | | | |
